2002
DOI: 10.1159/000063613
|View full text |Cite
|
Sign up to set email alerts
|

Nitric Oxide Synthesis Inhibition during Cerebral Hypoxemia and Reoxygenation with 100% Oxygen in Newborn Pigs

Abstract: The objective of our study was to evaluate the effects of Nσ-nitro-L-arginine methyl ester (L-NAME), an inhibitor of the nitric oxide (NO) pathway, on cerebral microcirculation during hypoxemia and reoxygenation with 100% oxygen in newborn pigs. Twenty-two pigs were randomized to hypoxemia [inspired fraction of oxygen (FIO2) 0.08; 20 min] and reoxygenation (FIO2 1.0; 60 min) or normoxia. The hypoxemic animals were further randomized to receive either an intravenous bolus inject… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
4
0

Year Published

2005
2005
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 61 publications
0
4
0
Order By: Relevance
“…In contrast to the neuroprotective effects of NO donors, there are reports in the literature suggesting that NO synthesis inhibition is beneficial in reducing functional and histological impairments induced by ischemic insult. Pretreatment of newborn pigs with L-NAME induced severe hypotension and reduced cerebral microcirculation during hypoxia, and NO synthesis inhibition during reoxygenation blunted the increase in NO concentration without the undesirable side effect of reducing cerebral blood flow, suggesting a beneficial effect of L-NAME in the reoxygenation phase (Kutzsche et al, 2002). Selective nNOS and iNOS inhibitors may be candidate treatments for acute ischemic stroke (Willmot et al, 2005a).…”
Section: Therapeutic Measures For Cerebral Ischemic Injury a L-arginmentioning
confidence: 99%
“…In contrast to the neuroprotective effects of NO donors, there are reports in the literature suggesting that NO synthesis inhibition is beneficial in reducing functional and histological impairments induced by ischemic insult. Pretreatment of newborn pigs with L-NAME induced severe hypotension and reduced cerebral microcirculation during hypoxia, and NO synthesis inhibition during reoxygenation blunted the increase in NO concentration without the undesirable side effect of reducing cerebral blood flow, suggesting a beneficial effect of L-NAME in the reoxygenation phase (Kutzsche et al, 2002). Selective nNOS and iNOS inhibitors may be candidate treatments for acute ischemic stroke (Willmot et al, 2005a).…”
Section: Therapeutic Measures For Cerebral Ischemic Injury a L-arginmentioning
confidence: 99%
“…During acute hypoxia, the fetal redistribution of cardiac output, and maintenance of brain perfusion has been demonstrated to be caused in part by nitric oxide (12)(13)(14). In both the sheep fetus and newborn pig, inhibition of nitric oxide synthase with N G -nitro-L-arginine methyl ester (L-NAME) during hypoxia has been demonstrated to attenuate changes in blood flow within the cerebral microcirculation (12,13).…”
mentioning
confidence: 99%
“…In both the sheep fetus and newborn pig, inhibition of nitric oxide synthase with N G -nitro-L-arginine methyl ester (L-NAME) during hypoxia has been demonstrated to attenuate changes in blood flow within the cerebral microcirculation (12,13). The circulatory adaptations that occur in the cerebral vascular beds of growthrestricted fetuses may involve specific compensatory adaptations in the nitric oxide synthase pathway.…”
mentioning
confidence: 99%
“…Newborn piglets resuscitated with 100% O 2 improved restoration of mean arterial blood pressure with no difference in amino acid build up in cerebral striatum (glutamate, taurine, and alanine) when compared to those resuscitated with 21% O 2 (63). Reoxygenation of asphyxiated piglets with 100% O 2 did not change cerebral perfusion but restored nitric oxide level in the cortex to a higher level compared to those resuscitated with 21% O 2 (65,66).…”
Section: Preclinical Studiesmentioning
confidence: 89%